- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06279806
The Effect of Mobile Health Application on Posttraumatic Growth in Women Diagnosed With Breast Cancer
February 19, 2024 updated by: Şengül Yaman Sözbir, Gazi University
The Effect of Mobile Health Application Based on Transformational Learning Theory on Posttraumatic Growth in Women Diagnosed With Breast Cancer
Breast cancer is the type of cancer that significantly affects women's health and causes the most mortal in women.
Despite the high incidence of breast cancer, women living after breast cancer are increasing due to advances in early diagnosis and effective treatment options.
Treatments are aimed at prolonging survival from breast cancer and enabling patients to live better.
Women repeatedly experience many vital crises such as the diagnosis of cancer, the difficulties of the treatment process and the fear of recurrence in the post-treatment period.
In the face of these crises, post-traumatic growth occurs when the individual's efforts to cope are transformed into positive psychological experiences.
Positive experiences lead to improvement in women's life, while negative experiences make it difficult to cope and adapt.
In order for post-traumatic growth to take place, women should be supported to cope with these negative emotions.
The care given to patients during cancer treatment should be such as to support the change process that will help individuals adapt to the new lifestyle.This information and supportive care content should include the topics that women will need in the long term after the treatment, in addition to the diagnosis and treatment process.
Generally, the education and counseling given to the patient at the last treatment appointment may be limited.
Due to the long period from the last treatment appointment to the control appointment, patients cannot interact with healthcare professionals for a long time.
Long-term side effects and needs of people may differ after breast cancer treatment.
For this reason, the need for information and consultancy services of healthcare professionals continues in this process as well.Today, the use of remotely accessible mechanisms in the treatment of breast cancer and in the follow-up of women after treatment is increasing.
It is thought that the mobile application to be developed within the scope of the project will increase the quality and efficiency of health services with an R&D and innovative approach and make these services accessible to everyone through digital technologies.
In addition, our study will set an example for nursing care to be presented in one of the priority areas of health, such as cancer, through digital technologies.
In our study, it is aimed to evaluate the effect of mobile health application based on Mezirow's Transformational Learning Theory on post-traumatic development in women with breast cancer.
The research is a single center, parallel group, stratified block randomized controlled experimental study.
It is planned to be conducted with 56 (intervention: 28, control: 28) women at Gazi University Health Research and Practice Center.
The training content to be included in the mobile application has been determined by considering the results of the studies in the literature and the recommendations of international guides to determine the problems experienced by women with breast cancer during the post-treatment period.
After receiving expert opinions on the subject content, the development process of the mobile application will be started.
In the implementation phase of the study, the women in the intervention group will start using the mobile application 1 week after completing the active treatment chemotherapy and radiotherapy) process.The implementation of the study will last 8 weeks.
At the end of eight weeks, data collection tools will be applied to the women.
The final tests will be repeated 4 weeks after the end of the application.
Starting from this period, women in the control group who want to use the application will also be included in the mobile application system.
After completing the data collection tools, the analysis and reporting part will be started.
Statistical analyzes will be made using SPSS Package Program (IBM SPSS Statistics 27).
Student t test, Pearson Chi-square test, Independent Sample t test, Mann Whitney U test, One-Way Analysis of Variance or Friedman test will be used in the analyses.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Serap ALKAŞ, Research Assistant
- Phone Number: +90 554 877 88 02
- Email: serapalkas11@hotmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Being over 18 years of age
- Diagnosed with breast cancer Stage I-II-III-IV
- Having undergone breast cancer surgery
- To have completed cancer treatment,
- Being at the beginning of the remission period,
- Being able to read and write
- Having a cell phone with Android software
Exclusion Criteria:
- Having a diagnosed psychiatric illness,
- Receiving hormone therapy only,
- Having had any cancer before,
- Having a communication barrier (not speaking Turkish, speech/hearing impairment, etc.)
- Being visually impaired
Criteria for Exclusion from the Sample During the Study
- Not logging into the information and counseling panel of the mobile health application
- Wanting to leave study
- Failure to complete final tests
- Death of the participant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: İntervention Group
Mobile health application use
|
Women will be asked to use the app for at least 8 weeks.
In order to monitor the usage, the researcher will monitor whether the women log in to the "Information and Counseling" section from the admin panel.
Women who do not log in to the "Information and Counseling" section will be removed from the study at this stage.
A weekly reminder will be sent to women via the mobile application.
The questions asked by the participants through the question-and-answer section of the mobile health application will be examined every day and answered by the researcher between 10:00-11:00 every morning and 22:00-23:00 every evening.
Likewise, the content shared by women in the forum section of the mobile application will be checked daily by the researcher and content that is harmful to women will be removed.
|
Experimental: Control Group
Information of the breast cancer survivor period booklet
|
Women in the control group will be given information of the breast cancer survivor period booklet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Women's progression through the stages of grief
Time Frame: 12 week
|
Mean scores on the Grief Psychological Reactions to Loss of Health Scale Psychological Reactions Scale due to Loss of Health: The scale has 30 items and is a 5-point Likert type (1: never, 5: always).
The scale does not have a total score.
Evaluation is made according to the scores obtained from the sub-dimensions.
It is seen that as the score obtained from the sub-dimensions increases, there is an increase in the number of people experiencing each of the stages of grief.
The scale has two different evaluations and two different subscale ratings.
|
12 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Women's increased level of posttraumatic development
Time Frame: 12 week
|
Post-Traumatic Development Scale in Cancer Patients: The scale consists of 23 Likert-type scale items scored between 0-5.
It is evaluated between "0" (I have never experienced it) and "5" (I have experienced it a lot).
The lowest score to be obtained from the scale is 0, the highest score is 115, and the higher the score obtained from the scale, the more the individual develops after the trauma.
|
12 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 28, 2024
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
October 30, 2024
Study Registration Dates
First Submitted
February 4, 2024
First Submitted That Met QC Criteria
February 19, 2024
First Posted (Actual)
February 28, 2024
Study Record Updates
Last Update Posted (Actual)
February 28, 2024
Last Update Submitted That Met QC Criteria
February 19, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SerapAlkas
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Grief
-
Universitat Jaume ICompleted
-
Memorial Sloan Kettering Cancer CenterCalvary Hospital, Bronx, NYCompleted
-
Ludwig-Maximilians - University of MunichCompleted
-
University of SaskatchewanSaskatchewan Health Research FoundationCompleted
-
NYU Langone HealthTerminated
-
Ersta Sköndal University CollegeCompleted
-
University of TromsoUnknownComplicated Grief
-
Mayo ClinicRecruiting
-
Universite du Quebec en OutaouaisFonds de la Recherche en Santé du Québec; Canadian Research Chair in Family...Unknown
Clinical Trials on Mobile health application use
-
University of ValenciaCompletedObsessive-Compulsive DisorderSpain
-
Agri Ibrahim Cecen UniversityAtaturk UniversityNot yet recruiting
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
Vanderbilt University Medical CenterOhio State UniversityActive, not recruitingSickle Cell DiseaseUnited States
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
University of CadizCompleted
-
Beijing Friendship HospitalNot yet recruitingLiver Cirrhosis | Hepatitis B
-
University of LincolnLincolnshire Partnership NHS Foundation TrustCompletedPsychological DistressUnited Kingdom
-
Hospital Clinic of BarcelonaCompletedChronic Disease | Multiple Chronic ConditionsSpain